Innovation
5 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 59 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Social engagement
Social engagement: 3.4K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
8 investors on record; lead investors include SOSV, xista, tecnet equity.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 50% |
| Accelerator & incubator | 1 | 13% |
| Other / undisclosed | 3 | 38% |
Recent activity
16 Jun 2026
Event
BIO International Convention
20 May 2026
Event
Antibody Engineering & Therapeutics Europe conference
16 Apr 2026
Event
Biotech Days Panel - Engineering Success: How Partnerships Transform Early Biotech into Fundable Ventures